medibeacon.comHealthcare / BioTech & PharmaFounded: 2011Funding to Date: $187.56MM
MediBeacon is a developer of novel light-activated agents designed to enable medical innovations.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/07/2023 | Series 3 | $26.22MM | $xx.xx | $377.6MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
364,224
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|
||||||
08/29/2019 | Series 2A | $20.27MM | $xx.xx | $413.41MM | Huadong Medicine Company | |
Price per Share
$xx.xx
Shares Outstanding
299,290
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Huadong Medicine Company
|
||||||
08/29/2019 | Series 2B | $15MM | $xx.xx | $413.41MM | Huadong Medicine Company | |
Price per Share
$xx.xx
Shares Outstanding
177,094
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Huadong Medicine Company
|
||||||
11/26/2018 | Series 1 | $45.29MM | $xx.xx | $90.58MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,723,523
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|